Intensive Care Nurses’ Knowledge About Use of Neuromuscular Blocking Agents in Patients With Respiratory Failure | Citedby Results | American Journal of Critical Care | American Association of Critical-Care Nurses

Skip to Main Content

Skip Nav Destination

Intensive Care Nurses’ Knowledge About Use of Neuromuscular Blocking Agents in Patients With Respiratory Failure

Am J Crit Care (2015) 24 (5): 431–439.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Acute Kidney Injury Survivor Care Following Hospital Discharge: A Mixed-Methods Study of Nephrologists and Primary Care Providers

Heather P. May
Abby K. Krauter
Dawn M. Finnie
Rozalina G. McCoy
Kianoush B. Kashani
Joan M. Griffin
Erin F. Barreto
Joe Herges
Andrea Kattah
Brenda Anderson
Angeliki Tinaglia
Lauri Meade

Kidney Medicine (2023) 5 (4): 100586.

Impact of ocular care training of nursing staff on the incidence of ocular surface disorder in medical intensive care unit patients

Aditi Pai
Atul Kamath
Indravadan Vasava
Dhananjay Bhosale
Gokulnath Nambiar

Indian Journal of Ophthalmology (2023) 71 (4): 1446.

Why is the Implementation of Beta-Lactam Therapeutic Drug Monitoring for the Critically Ill Falling Short? A Multicenter Mixed-Methods Study

Erin F. Barreto
Pooja N. Chitre
Kathleen H. Pine
Kathryn K. Shepel
Andrew D. Rule
Mohammad H. Alshaer
Mohd Hafiz Abdul Aziz
Jason A. Roberts
Marc H. Scheetz
Sara E. Ausman
Lindsay N. Moreland-Head
Christina G. Rivera
Paul J. Jannetto
Kristin C. Mara
Kasey R. Boehmer

Therapeutic Drug Monitoring (2023) 45 (4): 508.

Comparative efficacy of various preventive methods for exposure keratopathy among critically ill patients: A network meta-analysis of randomized controlled trials

Li Yao
Yuhong Luo
Yinhua Wang
Zhigang Zhang
Jinhui Tian
Liping Yang
Peng Cai
Ying Gu
Yaling Li

International Journal of Nursing Studies (2021) 118: 103926.

Provider perspectives on beta-lactam therapeutic drug monitoring programs in the critically ill: a protocol for a multicenter mixed-methods study

Erin F. Barreto
Andrew D. Rule
Mohammad H. Alshaer
Jason A. Roberts
Mohd Hafiz Abdul Aziz
Marc H. Scheetz
Kristin C. Mara
Paul J. Jannetto
Ognjen Gajic
John C. O’Horo
Kasey R. Boehmer

Implementation Science Communications (2021) 2 (1)

Critical Care Considerations in Adult Patients With Influenza-Induced ARDS

Rachel E. Smith
Megan M. Shifrin

Critical Care Nurse (2020) 40 (5): 15.

Nursing Considerations When Using Neuromuscular Blocking Agents to Assist With Intubation

Grant Blauvelt
Kailee Burdick
Emily J. Cannon

Critical Care Nursing Quarterly (2019) 42 (1): 30.

A PRÁXIS MÉDICA NO PRONTO ATENDIMENTO DIANTE DO PACIENTE COM SEQUELAS CRÔNICAS: CULPA, TEMOR E COMPAIXÃO

Janaína de Souza Aredes
Karla Cristina Giacomin
Josélia Oliveira Araújo Firmo

Trabalho, Educação e Saúde (2018) 16 (3): 1177.

Exposure keratopathy: Incidence, risk factors and impact of protocolised care on exposure keratopathy in critically ill adults

Obaid Kousha
Zubaid Kousha
Jonathan Paddle

Journal of Critical Care (2018) 44: 413.

Incidence, risk factors and impact of protocolised care on exposure keratopathy in critically ill adults: a two-phase prospective cohort study

Obaid Kousha
Zubaid Kousha
Jonathan Paddle

Critical Care (2018) 22 (1)

Perceived safety and efficacy of neuromuscular blockers for acute respiratory distress syndrome among medical intensive care unit practitioners: A multicenter survey

Heather Torbic
Seth R. Bauer
Heather A. Personett
Amy L. Dzierba
Joanna L. Stollings
Lindsay P. Ryder
Craig E. Daniels
Sean M. Caples
Erin N. Frazee

Journal of Critical Care (2017) 38: 278.

Aggrastat-Argatroban Mix-ups Don't Expect Radiofrequency Identification Stock Systems to be Perfect Paralyzed by Mistakes: Reassess the Safety of Neuromuscular Blockers in Your Facility

Michael R. Cohen
Judy L. Smetzer

Hospital Pharmacy (2016) 51 (11): 877.